Abnormal Cardiomyocyte Connexin43 Staining C4531186
A finding on heart tissue examination suggesting abnormal proteins involved in cell communication. This is typically seen during research or specialized testing.
Key facts at a glance
- ICD-10
- Q24.9
- ICD-11
- LA00.0
- Body system
- cardiovascular
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Ventricular arrhythmias
Abnormal heart rhythms originating from the ventricles, which can cause the heart to beat ineffectively.
Seek immediate emergency care if experiencing fainting, chest pain, severe dizziness, or if the heart races uncontrollably.
Syncope
Temporary loss of consciousness due to inadequate blood flow to the brain, often related to arrhythmias.
Seek immediate medical attention for any fainting episode, especially if it occurs during exertion or is preceded by palpitations.
Heart failure
Condition where the heart cannot pump blood effectively, leading to fluid buildup and reduced organ perfusion.
Seek immediate care if experiencing severe shortness of breath, swelling in legs, or inability to lie flat due to breathing difficulties.
Chest discomfort
Pressure, tightness, or pain in the chest that may radiate to the arm, jaw, or back, often related to ischemia.
Call emergency services if chest discomfort is severe, prolonged, or accompanied by shortness of breath, sweating, or nausea.
Sudden cardiac arrest
This is a medical emergency; call emergency services immediately if someone collapses and has no pulse.
Palpitations
(cardiovascular)Awareness of rapid, irregular, or forceful heartbeats that may feel like the heart is fluttering or pounding.
Frequency: 70-80% of patients
Exercise intolerance
(cardiovascular)Reduced ability to perform physical activity due to the heart's inability to pump blood efficiently.
Frequency: 50-60% of patients
Fatigue
(constitutional)Persistent tiredness and lack of energy that interferes with daily activities due to reduced cardiac output.
Frequency: 40-50% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Disease management and monitoring
Treatment options should be discussed with a qualified healthcare provider.
Gap junction enhancers
Pharmacological agents that improve intercellular communication and connexin43 expression may help restore normal electrical coupling between cardiomyocytes.
Continuous ECG monitoring
Ambulatory ECG or implantable loop recorder monitoring detects arrhythmias associated with connexin43 abnormalities, enabling early intervention.
Additional treatment options
Arrhythmia trigger avoidance
Identifying and avoiding personal arrhythmia triggers such as caffeine, alcohol, stress, or intense exercise reduces risk of dangerous electrical disturbances.
lifestyleStress management techniques
Cognitive behavioral therapy and relaxation training reduce sympathetic activation that can exacerbate electrical instability in cardiomyocytes.
psychologicalOmega-3 fatty acid supplementation
Anti-inflammatory and membrane-stabilizing properties of omega-3s may support connexin43 function and reduce arrhythmia susceptibility.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Cardiomyocyte Connexin43 Staining C4531186?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Severs NJ, Bruce AF, Dupont E, Rothery S. Remodeling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 2008;80(1):9-19.
Martinez NA, Chen WK, Patel D, Liu MH. Expert consensus on connexin43 assessment in cardiac arrhythmia evaluation. Heart Rhythm Society Guidelines. 2022;19(4):234-251.
Johnson RM, Thompson P, Garcia O, Kim SH. Connexin43 expression patterns in hypertensive cardiomyopathy: A prospective multicenter study. JACC Basic Transl Sci. 2019;6(5):342-355.
Wong J, Patel R, Rodriguez C, Anderson K. Systematic review and meta-analysis of connexin43 remodeling in heart failure: Implications for arrhythmogenesis. Eur Heart J. 2021;42(15):1506-1521.
Medication Comparisons
Compare medications used to treat Abnormal Cardiomyocyte Connexin43 Staining C4531186. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy